News

Despite its well-publicised problems, the FDA is a happy place for ASX biotechs seeking drug or device approvals.
Three in four Australians want tech giants banned from using local content to train AI systems without permission or ...
The Aussie bourse has had a strong start to the week with the S&P/ASX 200 finishing Monday up 0.43% to hit a fresh 100-day high.
Dual listing in the US offers access to the world’s largest source of capital and could serve to increase exposure to ...
Sovereign Metals (ASX:SVM) has confirmed the fleet design and mining method for its Kasiya graphite-rutile project DFS in ...
But Brazil’s Vale, the world’s largest and most experienced producer of high-grade iron ore, has already promised US$138m in ...
The ASX cruised higher on Monday with lithium names going full throttle after CATL’s mine shutdown sent traders scrambling ...
The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast ...
MPK has returned broad, high-grade gold results of up to 75m at 6.11g/t from 427m at the flagship Ferké gold project in Côte d’Ivoire.
The US Food and Drug Administration has 'suggested' to Syntara that it should carry out an additional myelofibrosis study with a control arm.
Results from ongoing diamond drilling by Many Peaks Minerals (ASX:MPK) at the Ferké gold project in Côte d’Ivoire have delivered.
Nordic Resources (ASX:NNL) appoints Henrik Grind as country manager to oversee the company's exploration across its Finnish portfolio.